These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9541124)

  • 1. Measurement of free fatty acid kinetics during non-equilibrium tracer conditions in man: implications for the estimation of the rate of appearance of free fatty acids.
    Riemens SC; Dullaart RP; Franssen EJ; Piers DA; Reitsma WD; Sluiter WJ
    Eur J Clin Invest; 1998 Feb; 28(2):108-14. PubMed ID: 9541124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
    J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced escape of non-esterified fatty acids from tissue uptake: its role in impaired insulin-induced lowering of total rate of appearance in obesity and Type II diabetes mellitus.
    Riemens SC; Sluiter WJ; Dullaart RP
    Diabetologia; 2000 Apr; 43(4):416-26. PubMed ID: 10819234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choice of infusion-sampling mode for tracer studies of free fatty acid metabolism.
    Jensen MD; Rogers PJ; Ellman MG; Miles JM
    Am J Physiol; 1988 May; 254(5 Pt 1):E562-5. PubMed ID: 3364559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty Acids, Obesity and Insulin Resistance.
    Arner P; Rydén M
    Obes Facts; 2015; 8(2):147-55. PubMed ID: 25895754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What does the measurement of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean?
    Mittendorfer B; Liem O; Patterson BW; Miles JM; Klein S
    Diabetes; 2003 Jul; 52(7):1641-8. PubMed ID: 12829627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished plasma free fatty acid clearance in obese subjects.
    Nestel PJ; Ishikawa T; Goldrick RB
    Metabolism; 1978 May; 27(5):589-97. PubMed ID: 642829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle.
    Blaak EE; Wagenmakers AJ; Glatz JF; Wolffenbuttel BH; Kemerink GJ; Langenberg CJ; Heidendal GA; Saris WH
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E146-54. PubMed ID: 10893334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate utilization in non-obese Type II diabetic patients at rest and during exercise.
    Borghouts LB; Wagenmakers AJ; Goyens PL; Keizer HA
    Clin Sci (Lond); 2002 Dec; 103(6):559-66. PubMed ID: 12444908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic studies of plasma free fatty acid and triglyceride metabolism in man.
    Eaton RP; Berman M; Steinberg D
    J Clin Invest; 1969 Aug; 48(8):1560-79. PubMed ID: 5796365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained endogenous glucose production, diminished lipolysis and non-esterified fatty acid appearance and oxidation in non-obese women at high risk of type 2 diabetes.
    Forbes S; Robinson S; Dungu J; Anyaoku V; Bannister P; Forster D; Dissanayake S; McCarthy MI; MacDonald IA; Venkatesan S; Johnston DG
    Eur J Endocrinol; 2006 Sep; 155(3):469-76. PubMed ID: 16914602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
    Pontiroli AE; Manzoni MF; Malighetti ME; Lanzi R
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.
    Abbasi F; Kamath V; Rizvi AA; Carantoni M; Chen YD; Reaven GM
    Diabetes Care; 1997 Dec; 20(12):1863-9. PubMed ID: 9405908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
    Oakes ND; Thalén PG; Jacinto SM; Ljung B
    Diabetes; 2001 May; 50(5):1158-65. PubMed ID: 11334421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes.
    Carpentier A; Mittelman SD; Bergman RN; Giacca A; Lewis GF
    Diabetes; 2000 Mar; 49(3):399-408. PubMed ID: 10868961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of saturated, monounsaturated, and polyunsaturated fatty acids in humans.
    Nelson RH; Mundi MS; Vlazny DT; Smailovic A; Muthusamy K; Almandoz JP; Singh E; Jensen MD; Miles JM
    Diabetes; 2013 Mar; 62(3):783-8. PubMed ID: 23274886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and initial evaluation of a novel method for assessing tissue-specific plasma free fatty acid utilization in vivo using (R)-2-bromopalmitate tracer.
    Oakes ND; Kjellstedt A; Forsberg GB; Clementz T; Camejo G; Furler SM; Kraegen EW; Olwegård-Halvarsson M; Jenkins AB; Ljung B
    J Lipid Res; 1999 Jun; 40(6):1155-69. PubMed ID: 10357848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight reduction and the impaired plasma-derived free fatty acid oxidation in type 2 diabetic subjects.
    Blaak EE; Wolffenbuttel BH; Saris WH; Pelsers MM; Wagenmakers AJ
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1638-44. PubMed ID: 11297597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free fatty acid kinetics in the late phase of postexercise recovery: importance of resting fatty acid metabolism and exercise-induced energy deficit.
    Magkos F; Mohammed BS; Patterson BW; Mittendorfer B
    Metabolism; 2009 Sep; 58(9):1248-55. PubMed ID: 19500809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise.
    Blaak EE; van Aggel-Leijssen DP; Wagenmakers AJ; Saris WH; van Baak MA
    Diabetes; 2000 Dec; 49(12):2102-7. PubMed ID: 11118013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.